Individual Investors Own 42% of Beijing Wandong Medical Technology Co., Ltd. (SHSE:600055) Shares but Private Companies Control 48% of the Company
Individual Investors Own 42% of Beijing Wandong Medical Technology Co., Ltd. (SHSE:600055) Shares but Private Companies Control 48% of the Company
Every investor in Beijing Wandong Medical Technology Co., Ltd. (SHSE:600055) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 48% to be precise, is private companies. Put another way, the group faces the maximum upside potential (or downside risk).
Meanwhile, individual investors make up 42% of the company's shareholders.
Let's take a closer look to see what the different types of shareholders can tell us about Beijing Wandong Medical Technology.
See our latest analysis for Beijing Wandong Medical Technology
SHSE:600055 Ownership Breakdown November 11th 2022What Does The Institutional Ownership Tell Us About Beijing Wandong Medical Technology?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
Beijing Wandong Medical Technology already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Beijing Wandong Medical Technology's historic earnings and revenue below, but keep in mind there's always more to the story.
SHSE:600055 Earnings and Revenue Growth November 11th 2022Hedge funds don't have many shares in Beijing Wandong Medical Technology. Looking at our data, we can see that the largest shareholder is Midea Investment Holding Co., Ltd. with 45% of shares outstanding. In comparison, the second and third largest shareholders hold about 3.4% and 2.9% of the stock.
After doing some more digging, we found that the top 3 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is some analyst coverage of the stock, but it could still become more well known, with time.
Insider Ownership Of Beijing Wandong Medical Technology
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
We can see that insiders own shares in Beijing Wandong Medical Technology Co., Ltd.. It is a pretty big company, so it is generally a positive to see some potentially meaningful alignment. In this case, they own around CN¥524m worth of shares (at current prices). If you would like to explore the question of insider alignment, you can click here to see if insiders have been buying or selling.
General Public Ownership
The general public-- including retail investors -- own 42% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
Private Company Ownership
It seems that Private Companies own 48%, of the Beijing Wandong Medical Technology stock. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.
Next Steps:
It's always worth thinking about the different groups who own shares in a company. But to understand Beijing Wandong Medical Technology better, we need to consider many other factors. To that end, you should be aware of the 2 warning signs we've spotted with Beijing Wandong Medical Technology .
If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
北京萬東醫療科技股份有限公司(上證號:600055)的每一位投資者都應該意識到最強大的股東羣體。持有該公司股份最多的集團,準確地説約為48%,是私營公司。換句話説,該集團面臨着最大的上行潛力(或下行風險)。
與此同時,個人投資者佔該公司股東的42%。
讓我們仔細看看不同類型的股東能告訴我們什麼關於北京萬東醫療科技。
查看我們對北京萬東醫療科技的最新分析
上海證交所:600055所有權明細2022年11月11日關於北京萬東醫療科技,機構持股告訴了我們什麼?
機構投資者通常將自己的回報與經常跟蹤的指數的回報進行比較。因此,他們通常確實會考慮收購被納入相關基準指數的較大公司。
北京萬東醫療科技已有機構在股份登記處登記。事實上,他們在該公司擁有可觀的股份。這可以表明該公司在投資界具有一定的公信力。然而,最好警惕依賴機構投資者帶來的所謂驗證。他們也一樣,有時也會犯錯。當多家機構持有一隻股票時,它們總是面臨“擁擠交易”的風險。當這樣的交易出錯時,多方可能會競相快速拋售股票。在一家沒有增長曆史的公司,這一風險更高。你可以在下面看到北京萬東醫療科技的歷史收益和收入,但請記住,故事中總是有更多的故事。
上海證交所:600055收益和收入增長2022年11月11日對衝基金在北京萬東醫療科技的股份並不多。查看我們的數據可以看到,第一大股東是美的投資控股有限公司,持有45%的流通股。相比之下,第二大和第三大股東分別持有約3.4%和2.9%的股份。
經過進一步挖掘,我們發現,前3名股東合計控制了公司一半以上的股份,這意味着他們擁有相當大的權力來影響公司的決策。
研究機構持股是衡量和篩選股票預期表現的好方法。通過研究分析師的情緒,也可以達到同樣的效果。有一些分析師對該股的報道,但隨着時間的推移,它仍可能變得更加廣為人知。
北京萬東醫療科技的內部人所有權
不同國家對內部人的定義可能略有不同,但董事會成員總是算數的。管理層最終要向董事會負責。然而,經理人擔任執行董事會成員並不少見,尤其是如果他們是創始人或首席執行官的話。
內部人持股是積極的,當它標誌着領導層像公司的真正所有者一樣思考時。然而,高內部人持股也可以給公司內部的一個小團體帶來巨大的權力。在某些情況下,這可能是負面的。
我們可以看到,內部人士持有北京萬東醫療科技有限公司的股份。這是一家相當大的公司,因此看到一些潛在的有意義的結盟通常是積極的。在這種情況下,他們擁有價值約5.24億元人民幣的股票(按當前價格計算)。如果你想探討內部人結盟的問題,你可以點擊這裏,看看內部人是一直在買入還是賣出。
一般公有制
包括散户投資者在內的普通公眾持有該公司42%的股份,因此不能輕易忽視。這種規模的所有權雖然可觀,但如果決策與其他大股東不同步,可能不足以改變公司政策。
私營公司所有權
看起來民營企業持有北京萬東醫療科技48%的股份。僅從這一事實很難得出任何結論,因此值得調查一下誰擁有這些私營公司。有時,內部人士或其他關聯方通過一家獨立的私人公司擁有上市公司的股份。
接下來的步驟:
擁有一家公司股票的不同集團總是值得考慮的。但要更好地瞭解北京萬東醫療科技,我們還需要考慮許多其他因素。為此,您應該意識到2個警告標誌我們發現了北京萬東醫療科技有限公司。
如果你更願意瞭解分析師對未來增長的預測,請不要錯過這一預期免費關於分析師預測的報告。
注:本文中的數字是使用過去12個月的數據計算的,指的是截至財務報表日期的最後一個月的12個月期間。這可能與全年的年度報告數字不一致。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧